Merck | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Adidas EUR 1.43B 1.02B 2025-03
Adyen EUR 9.97B 1.23B 2024-12
Akzo Nobel EUR 1.6B 297M 2025-03
Alcon AG USD 1.83B 112M 2024-12
Amadeus IT EUR 1.05B 35.1M 2024-12
Amarin USD 156.94M 58.98M 2024-09
AstraZeneca USD 5.23B 258M 2025-03
BASF EUR 2.91B 342M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Beiersdorf EUR 1.21B 7M 2024-12
Covestro EUR 539M 30M 2024-09
Danone EUR 1.48B 583M 2024-12
Fresenius EUR 2.28B 788M 2024-12
Fresenius Medical Care EUR 1.18B 191M 2024-12
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 9.86B 3.52B 2024-12
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 4.46B 594M 2025-03
GRIFOLS EUR 979.78M 334.84M 2024-12
Henkel EUR 2.89B 1.04B 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Infineon EUR 1.25B 552M 2024-12
Linde USD 4.85B 337M 2024-12
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Philips EUR 2.4B 594M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12



Merck Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.